CES

Digital

It’s been a decade since I first navigated the dazzling chaos of CES in Las Vegas. The buzz of innovation was thrilling, yet overwhelming.

Views & Analysis

A round-up of this week’s top digital healthcare news. Marco Ricci reports.

News

Chiesi has boosted its rare disease business with an agreement to buy KalVista and Ekterly, its oral drug for treating attacks in rare disease HAE.

Sales & Marketing

As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.